Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1458699

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1458699

Nicotine Replacement Therapy Global Market Report 2024

Published: Pre-Order
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

Nicotine replacement therapy is a medical strategy devised to aid individuals in quitting smoking or reducing nicotine dependence by administering controlled doses of nicotine without the harmful effects of tobacco smoke. Its primary objective is to mitigate withdrawal symptoms and cravings associated with smoking cessation, facilitating a smoother transition and enhancing long-term success rates.

Nicotine replacement therapy encompasses various products, including patches, gum, lozenges, inhalers, sprays, among others. Nicotine patches, a prominent component of this therapy, are specifically designed to assist individuals in their efforts to quit smoking or diminish nicotine dependency. These products are readily available through hospital pharmacies, retail pharmacies, and online platforms, accessible in diverse settings such as hospitals, addiction centers, and private residences.

The nicotine replacement therapy market research report is one of a series of new reports from The Business Research Company that provides nicotine replacement therapy market statistics, including nicotine replacement therapy industry global market size, regional shares, competitors with a nicotine replacement therapy market share, detailed nicotine replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the nicotine replacement therapy industry. This nicotine replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nicotine replacement therapy market size has grown strongly in recent years. It will grow from $2.99 billion in 2023 to $3.22 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth observed in the historic period can be attributed to various factors, including the implementation of public health initiatives, shifts in lifestyles, recommendations from physicians, increased market competition, and heightened consumer awareness regarding health-related issues.

The nicotine replacement therapy market size is expected to see strong growth in the next few years. It will grow to $4.10 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The anticipated growth in the forecast period can be attributed to several factors, including the emergence of new markets, the development of tailored therapies, government initiatives aimed at healthcare improvement, increased accessibility to healthcare services, and shifting demographics. Major trends expected during this period encompass continuous technological advancements, progressions in research methodologies, the integration of digital health solutions, the incorporation of digital therapeutics into healthcare practices, and the expansion of corporate wellness programs. These trends reflect a dynamic healthcare landscape characterized by innovation, digitalization, and a focus on improving patient outcomes and overall well-being.

The increasing prevalence of smoking-related diseases is anticipated to drive the expansion of the nicotine replacement therapy (NRT) market in the foreseeable future. Smoking-related diseases encompass a spectrum of health ailments directly attributed to tobacco consumption, particularly through smoking. NRT serves as a pivotal tool in smoking cessation efforts, aiding individuals in quitting smoking and thereby mitigating the risk of smoking-related diseases. This therapy is often complemented by counseling, support programs, and lifestyle modifications. For instance, data from the National Health Service (NHS) revealed a notable rise in hospital admissions due to smoking-related diseases, underscoring the pressing need for effective smoking cessation interventions. Consequently, the escalating incidence of smoking-related diseases is fueling the growth trajectory of the nicotine replacement therapy market.

The efforts of major companies in the nicotine replacement therapy market to innovate and introduce novel solutions, such as the Cigibud smoking cessation filters, are aimed at addressing the significant health risks associated with smoking. Smoking cessation filters represent a proactive approach to aiding individuals in quitting smoking by mitigating the intake of harmful ssubstances present in cigarettes. For example, Nanoclean Global Pvt. Ltd., an India-based nanotechnology startup company, unveiled Cigibud, touted as the world's first smoking cessation filter, in March 2023. Developed using patented nanofiber technology, Cigibud offers a scientifically validated approach to smoking cessation by systematically reducing nicotine levels. The filter's biodegradable and biocompatible design, featuring ultrafine pores that prevent the passage of even the smallest particles, underscores its effectiveness and safety. Inspired by nicotine replacement therapy (NRT) principles, Cigibud aims to empower individuals in their journey to quit smoking by progressively reducing tar and nicotine intake from cigarettes.

The partnership between Click Therapeutics Inc. and YouTurn Health Inc., established in March 2021, is a strategic initiative aimed at extending access to Click Therapeutics' clinically validated smoking cessation program, Clickotine. Clickotine is designed to address the pressing public health issue of smoking cessation by leveraging innovative digital health solutions. By collaborating with YouTurn Health Inc., a provider of a virtual health platform for mental health management, Click Therapeutics aims to broaden the reach of its smoking cessation program, ensuring that individuals struggling with nicotine addiction have access to evidence-based treatment options. This partnership highlights the importance of leveraging technology and collaboration to address behavioral disorders and improve public health outcomes related to smoking cessation.

Major companies operating in the nicotine replacement therapy market report are Pfizer Inc., Johnson & Johnson, Philip Morris International Inc., Bayer AG, Sanofi S.A., Abbott Laboratories, Novartis International AG, Imperial Brands, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Haleon Group of Companies, Perrigo Company plc, Reynolds American Inc., Cipla Limited, Swedish Match AB, Lucy Goods, Fertin Pharma Limited, Innokin Technology Co. Ltd., 22nd Century Group, Fontem Ventures, PAX Labs, Zydus Cadila, Gamucci Electronic Cigarettes, Revolymer plc

Asia-Pacific was the largest region in the nicotine replacement therapy market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotine replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nicotine replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nicotine replacement therapy market consists of revenues earned by entities by providing services such as relapse prevention, combination therapies, monitoring and adjustments, educational support, and customized treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The nicotine replacement therapy market also includes sales of nicoderm CQ, habitrol, nicoDerm, nicorette and nicotine nasal spray. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nicotine Replacement Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nicotine replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nicotine replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nicotine replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Patch; Gum; Lozenge; Inhaler; Spray; Other Products
  • 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
  • 3) By Location: Hospitals And Deaddiction Centers; Home
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Philip Morris International Inc.; Bayer AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r16681

Table of Contents

1. Executive Summary

2. Nicotine Replacement Therapy Market Characteristics

3. Nicotine Replacement Therapy Market Trends And Strategies

4. Nicotine Replacement Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Nicotine Replacement Therapy Market Size and Growth

  • 5.1. Global Nicotine Replacement Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Nicotine Replacement Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Nicotine Replacement Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Nicotine Replacement Therapy Market Segmentation

  • 6.1. Global Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Patch
  • Gum
  • Lozenge
  • Inhaler
  • Spray
  • Other Products
  • 6.2. Global Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • 6.3. Global Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Deaddiction Centers
  • Home

7. Nicotine Replacement Therapy Market Regional And Country Analysis

  • 7.1. Global Nicotine Replacement Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Nicotine Replacement Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Nicotine Replacement Therapy Market

  • 8.1. Asia-Pacific Nicotine Replacement Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Nicotine Replacement Therapy Market

  • 9.1. China Nicotine Replacement Therapy Market Overview
  • 9.2. China Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Nicotine Replacement Therapy Market

  • 10.1. India Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Nicotine Replacement Therapy Market

  • 11.1. Japan Nicotine Replacement Therapy Market Overview
  • 11.2. Japan Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Nicotine Replacement Therapy Market

  • 12.1. Australia Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Nicotine Replacement Therapy Market

  • 13.1. Indonesia Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Nicotine Replacement Therapy Market

  • 14.1. South Korea Nicotine Replacement Therapy Market Overview
  • 14.2. South Korea Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Nicotine Replacement Therapy Market

  • 15.1. Western Europe Nicotine Replacement Therapy Market Overview
  • 15.2. Western Europe Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Nicotine Replacement Therapy Market

  • 16.1. UK Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Nicotine Replacement Therapy Market

  • 17.1. Germany Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Nicotine Replacement Therapy Market

  • 18.1. France Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Nicotine Replacement Therapy Market

  • 19.1. Italy Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Nicotine Replacement Therapy Market

  • 20.1. Spain Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Nicotine Replacement Therapy Market

  • 21.1. Eastern Europe Nicotine Replacement Therapy Market Overview
  • 21.2. Eastern Europe Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Nicotine Replacement Therapy Market

  • 22.1. Russia Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Nicotine Replacement Therapy Market

  • 23.1. North America Nicotine Replacement Therapy Market Overview
  • 23.2. North America Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Nicotine Replacement Therapy Market

  • 24.1. USA Nicotine Replacement Therapy Market Overview
  • 24.2. USA Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Nicotine Replacement Therapy Market

  • 25.1. Canada Nicotine Replacement Therapy Market Overview
  • 25.2. Canada Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Nicotine Replacement Therapy Market

  • 26.1. South America Nicotine Replacement Therapy Market Overview
  • 26.2. South America Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Nicotine Replacement Therapy Market

  • 27.1. Brazil Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Nicotine Replacement Therapy Market

  • 28.1. Middle East Nicotine Replacement Therapy Market Overview
  • 28.2. Middle East Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Nicotine Replacement Therapy Market

  • 29.1. Africa Nicotine Replacement Therapy Market Overview
  • 29.2. Africa Nicotine Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Nicotine Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Nicotine Replacement Therapy Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Nicotine Replacement Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Nicotine Replacement Therapy Market Competitive Landscape
  • 30.2. Nicotine Replacement Therapy Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Philip Morris International Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Sanofi S.A.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Nicotine Replacement Therapy Market Other Major And Innovative Companies

  • 31.1. Abbott Laboratories
  • 31.2. Novartis International AG
  • 31.3. Imperial Brands
  • 31.4. GlaxoSmithKline plc
  • 31.5. Takeda Pharmaceutical Company Limited
  • 31.6. Haleon Group of Companies
  • 31.7. Perrigo Company plc
  • 31.8. Reynolds American Inc.
  • 31.9. Cipla Limited
  • 31.10. Swedish Match AB
  • 31.11. Lucy Goods
  • 31.12. Fertin Pharma Limited
  • 31.13. Innokin Technology Co. Ltd.
  • 31.14. 22nd Century Group
  • 31.15. Fontem Ventures

32. Global Nicotine Replacement Therapy Market Competitive Benchmarking

33. Global Nicotine Replacement Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Nicotine Replacement Therapy Market

35. Nicotine Replacement Therapy Market Future Outlook and Potential Analysis

  • 35.1 Nicotine Replacement Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Nicotine Replacement Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Nicotine Replacement Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!